Stabilized GHRH(1-44) Analog
Tesamorelin
N-terminally modified 44-amino-acid GHRH analog with enhanced enzymatic stability, studied in somatotroph signaling, IGF-1 axis and visceral adipose tissue research.
GHRH receptor signalingIGF-1 axis modelsVisceral adiposity research
Specifications
- CAS number
- 218949-48-5
- Molecular formula
- C221H366N72O67S
- Molecular weight
- 5135.86 g/mol
- Vial size
- 5 mg / vial
- Purity
- ≥ 99.0% (HPLC)
- Physical form
- Lyophilized white powder
- Storage
- -20 °C, protected from light
- Solubility
- Bacteriostatic water
Sequence
trans-3-hexenoyl-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-... -Arg-NH2 (44 aa)
Certificate of analysis
Each lot is released with a batch-numbered COA including RP-HPLC chromatogram, ESI-MS identification, sterility and endotoxin results. Reference the lot code on your vial to request the signed document.
Research use only
This material is intended strictly for in-vitro laboratory research. Not for human or veterinary use, diagnostic, therapeutic or food applications.
Scientific references
Selected peer-reviewed literature cited for research context only.